Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Development of Clostridium Difficile Associated Diarrhea

In brief

We have designed this study to measure the effect of normal flora supplementation, using available probiotics, on the incidence of Clostridium difficile-associated diarrhea in a population of general inpatients who are receiving antibiotics.

Key facts

Study ID

NCT01873872

Run by

St. Vincent's East, Birmingham, Alabama

People needed

120

Starts

2013-07-01

Expected to finish

2014-03-01

Last updated by the study team

2014-03-28

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Feeding tube in place
• Pregnancy
• Milk or soy allergy
• Sensitivity to lactose
• Immunocompromised defined as:
• Absolute neutrophil count (ANC) ≤ 500 cells/mm3
• HIV
• Cancer patient receiving chemotherapy or radiation therapy
• Immune deficiency
• Post organ transplant
• Participants will be withdrawn from the study if they develop any of the exclusion criteria during the hospitalization.

Where it is running

• St. Vincent's East — Birmingham, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.